Alimera Sciences, Inc. (ALIM) Social Stream

Alimera Sciences, Inc. (ALIM): $4.29

-0.26 (-5.71%)

POWR Rating

Component Grades













Alimera Sciences Inc (ALIM) Price Targets From Analysts

Use the tables below to see what analysts covering Alimera Sciences Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-29 1 $12 $12 $12 $4.55 163.74%

Price Target Last Issued October 29, 2021

The Trend in the Analyst Price Target

ALIM's average price target has moved down $2.25 over the prior 30 weeks.

ALIM reports an average of 95.56% for its upside potential over the past 40 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 0 18 15 16.38 9.67 69.39%
2021-06-05 0 18 15 16.38 10.28 59.34%
2021-01-30 3 18 10 13.50 6.72 100.89%
2021-09-18 4 18 12 14.83 4.86 205.14%
2021-04-25 0 18 14 15.88 10.70 48.41%

ALIM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations

Over the past 15 months, ALIM's average broker recommendation rating worsened by 1.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Alimera Sciences Inc's number of analysts covering the stock is higher than practically none of all US stocks.
  • In the context of all US stocks, Alimera Sciences Inc's variance in analysts' estimates is lower than nearly 100% of them.
  • Alimera Sciences Inc's average analyst price target is greater than 19.44% of Healthcare stocks.
  • In terms of how Alimera Sciences Inc fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 66.09% of that group.

Stocks similar to Alimera Sciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ALDX, ALBO, and AKUS.

Is ALIM a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6457 seconds.